首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1516093

心臟人工智慧监测和诊断市场，按产品（硬体、软体解决方案、服务）、类型（心臟诊断、监测）、应用（心律不整、中风、缺血性心臟病、狭窄）、最终用途和预测，2024 - 2032

Cardiac AI Monitoring and Diagnostics Market, By Product (Hardware, Software Solutions, Services), Type (Cardiac Diagnostics, Monitoring), Application (Cardiac Arrhythmias, Stroke, Ischemic Heart Disease, Stenosis), End-use & Forecast, 2024 - 2032

出版日期: 2024年04月04日 | 出版商:

Global Market Insights Inc. | 英文 189 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在心血管疾病（CVD）盛行率不断上升以及人口老化的推动下，心臟人工智慧监测和诊断市场预计在 2024 年至 2032 年期间复合年增长率将超过 26.9%。根据世界卫生组织的数据，心血管疾病 (CVD) 是死亡的主要原因，全球每年估计有 1,790 万人死亡。

随着心血管疾病成为发病和死亡的主要原因，需要有效的诊断工具来进行早期检测和管理。人工智慧比传统诊断方法有了显着改进，可以对复杂的心臟资料进行准确、即时的分析，同时实现早期、准确的诊断。人工智慧与穿戴式装置和远端监测技术的整合还可以实现心臟健康的持续监测，这对于及时干预和个人化患者护理非常重要。

对卫生技术的重大投资和政府支持政策将鼓励人工智慧在医学研究中的采用。在心臟监测中使用人工智慧驱动的解决方案依赖巨量资料的不断增长和机器学习演算法的进步，以提高系统的预测准确性和效率。科技公司和医疗保健提供者之间合作开发和部署新的人工智慧解决方案也正在推动市场成长。

心臟人工智慧监测和诊断产业分为产品、类型、应用、最终用途和地区。

根据产品，软体解决方案领域的市场规模预计到 2032 年将创下强劲的复合年增长率，因为它能够提供先进的演算法和机器学习模型，从而提高心臟诊断的准确性、有效性和范围。该软体解决方案支援即时资料分析、远端监控和预测分析，同时让医疗保健提供者全面了解患者的心臟健康状况。易于使用的介面以及与医疗设备和电子健康记录 (EHR) 系统的互通性可简化临床工作流程并改善患者治疗结果，这将促进该细分市场的成长。

由于需要持续即时追踪心臟健康状况，预计心臟监测类型领域的心臟人工智慧监测和诊断市场在 2024 年至 2032 年间将大幅复合年增长率。人工智慧驱动的心臟监测设备，例如智慧穿戴设备和植入式感测器，可以准确、快速地了解心律、血压和其他重要参数。将人工智慧融入心臟监测有助于对患者进行远端监测，同时减少频繁去医院的需要，并改善慢性心臟衰竭的管理。

亚太地区心臟人工智慧监测和诊断产业将在2024年至2032年间持续成长。中国、印度和日本数位健康技术的快速采用和医疗保健的改善正在促进人工智慧与心臟病学的整合。政府在医疗保健创新方面的倡议和大量投资将进一步支持该地区由人工智慧驱动的心臟监测和诊断工具的开发。

产业生态系统分析
产业影响力
- 成长动力
  - 心血管疾病盛行率上升
  - 远端监控解决方案的需求不断增长
  - 技术进步
  - 日益关注精准医疗
- 产业陷阱与挑战
  - 实施成本高
  - 互通性和整合有限
成长潜力分析
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
硬体
软体解决方案
服务

第 6 章：市场估计与预测：按类型，2021 - 2032

主要趋势
心臟诊断
- 影像学
- 基于心电图
- 其他诊断技术
心臟监测

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
心律不整
中风
缺血性心臟病
狭窄
其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
专科诊所
诊断中心
研究和学术机构
其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

CardiAI
Cleerly, Inc.
DiA Imaging Analysis
HeartVista Inc.
IDOVEN
Koninklijke Philips N.V.
RSIP Vision
Tempus
Ultrasight
Ultromics Limited
Viz.ai, Inc.

简介目录

Product Code: 8858

Cardiac AI monitoring and diagnostics market is estimated to record over 26.9% CAGR during 2024-2032, driven by the increasing prevalence of cardiovascular diseases (CVDs), coupled with the aging population. As per WHO, cardiovascular diseases (CVDs) are the leading cause of mortality, with an estimated 17.9 million deaths per year worldwide.

With CVDs emerging as the major cause of morbidity and mortality, effective diagnostic tools are needed for early detection and management. AI offers significant improvements over traditional diagnostic methods for providing accurate, real-time analysis of complex cardiac data while allowing early and accurate diagnosis. The integration of AI with wearable devices and remote monitoring techniques is also enabling continuous monitoring of heart health, which is important for timely interventions and personalized patient care.

Major investments in health technology and supportive government policies will encourage the adoption of AI in medical research. The use of AI-driven solutions in cardiac monitoring relies on the growing availability of big data and advancements in ML algorithms to increase the predictive accuracy and efficiency of the systems. Partnerships between tech companies and healthcare providers to develop and deploy new AI solutions are also driving the market growth.

The cardiac AI monitoring and diagnostics industry is segmented into product, type, application, end-use and region.

Based on product, the market size from the software solutions segment is slated to record strong CAGR through 2032 due to its ability to provide advanced algorithms and ML models that increase the accuracy, efficacy, and scope of cardiac diagnosis. This software solution enables real-time data analytics, remote monitoring, and predictive analytics while giving healthcare providers a holistic view of the patient's cardiac health. Easy-to-use interfaces and interoperability with medical devices and electronic health record (EHR) systems to streamline clinical workflow and improve patient outcomes will add to the segment growth.

Cardiac AI monitoring and diagnostics market from the cardiac monitoring type segment is projected to observe substantial CAGR between 2024 and 2032, owing to the need for continuous and real-time tracking of heart health. AI-powered heart monitoring devices, such as smart wearables and implantable sensors, provide accurate and rapid insights into heart rhythms, blood pressure and other vital parameters. The integration of AI into cardiac monitoring facilitates the remote monitoring of patients while reducing the need for frequent hospital visits as well as improving the management of chronic heart failure.

Asia Pacific cardiac AI monitoring and diagnostics industry will witness sustained growth rate between 2024 and 2032. This is attributed to the increasing burden of cardiovascular diseases, driven by lifestyle changes, urbanization, and aging population. The rapid adoption of digital health technologies and improvements in healthcare in China, India and Japan are facilitating the integration of AI into cardiology. Government initiatives and large investments in healthcare innovation will further support the development and AI-powered cardiac monitoring and diagnostic tools in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of cardiovascular diseases
  - 3.2.1.2 Growing demand for remote monitoring solutions
  - 3.2.1.3 Technological advancements
  - 3.2.1.4 Increasing focus on precision medicine
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High implementation costs
  - 3.2.2.2 Limited interoperability and integration
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Hardware
5.3 Software solutions
5.4 Services

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Cardiac diagnostics
- 6.2.1 Imaging
- 6.2.2 ECG-based
- 6.2.3 Other diagnostic techniques
6.3 Cardiac monitoring

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Cardiac arrhythmias
7.3 Stroke
7.4 Ischemic heart disease
7.5 Stenosis
7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Specialty clinics
8.4 Diagnostic centers
8.5 Research and academic institutes
8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa